|
 |
clopidogrel bisulfateThis page contains recent news articles, when available, and an overview of clopidogrel bisulfate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....who developed Plavix(R)/Iscover(R) (clopidogrel bisulfate) - should not have been accepted by a regulatory body within the European Union before this PharmaLive.com (press release), Sanofi-aventis News - Jul 31, 2008 ...who developed Plavix(R)/Iscover(R) (clopidogrel bisulfate) - should not have been accepted by a regulatory body within the European Union before this PR Newswire (press release), Portola Raises $60M in Series C Extension - Jul 9, 2008 Portola is also developing PRT060128, an antiplatelet agent designed to compete with the blockbuster Plavix (clopidogrel bisulfate, Bristol-Myers Squibb Co. TMCnet Plavix: concurrents génériques sur le marché allemand pas avant le ... - Jul 31, 2008 Selon le groupe français toutefois, le clopidogrel besilate est un sel différent de celui de son anticoagulant Plavix (clopidogrel bisulfate), son deuxième Daily Bourse, êµë‚´ ì œë„¤ë¦ ì?˜ì•½í’ˆ 가격 ë¯¸êµ ì œë„¤ë¦ ì ˆë°˜ 수준 불과 - Jul 15, 2008 ...ë˜? í•í˜ˆì „ì œ 플ë?¼ë¹…스(성분 clopidogrel bisulfate)ì • 75mgì?€ 우리나ë?¼ëŠ” 1206ì›?, 미êµì?´ 4335ì›?으로 3.6ë°° 비싸다. 어린ì?´í•´ì—´ì œ ì?´ë¶€í”„로펜(성분 ibuprofen)시럽ì?€ 마ì?´ë?°ì?¼ë¦¬, Plavix: décision d'un tribunal allemand contre Sanofi, qui va ... - Jul 29, 2008 Selon le groupe français, le clopidogrel besilate est un sel différent de celui de son anticoagulant Plavix (clopidogrel bisulfate), son deuxième médicament Daily Bourse, German Regulators Approve Generic Heart Drug - Jun 4, 2008 Clopidogrel is a major moneymaker for sanofi and BMS, which market it as Plavix (clopidogrel bisulfate) in the US and Iscover elsewhere. FDA news (subscription), FDA Action on Prasugrel Delayed Until September - Jun 25, 2008 ...which compared the drug in 13600 patients with Bristol-Myers Squibb and sanofi-aventis’ blockbuster antiplatelet drug Plavix (clopidogrel bisulfate). FDA news (subscription), Sanofi takes legal action as generic clopidogrel gets German OK - May 29, 2008 However the firm notes that these registrations refer to a different salt of clopidogrel than the one found in Plavix/Iscover (clopidogrel bisulfate) “and Pharma Times (subscription), Statement on Third-party Clopidogrel Applications in Germany - May 28, 2008 These registrations refer to a different salt of clopidogrel than the one of Plavix® (clopidogrel bisulfate), and the products are labelled only for a PharmaLive.com (press release), UPDATE: Schweizerhall Says It's Near Generic Plavix Launch - May 9, 2008 ...a generic version of Plavix in the US Dr. Reddy's (RDY) received marketing approval from the US Food & Drug Administration for Clopidogrel Bisulfate. CNNMoney.com KAI, BMS Join Forces in $227M Heart Drug Deal - May 13, 2008 ...as Pravachol (pravastatin sodium) and Plavix (clopidogrel bisulfate), "you can't do everything inside the four walls of your company," Daniels said. TMCnet Generic Plavix opens door for API manufacturers - May 13, 2008 ...with approval of its generic version of Bristol-Myers Squibb's (BSM) and Sanofi-Aventis' Plavix (clopidogrel bisulfate) in Germany "expected shortly". In-PharmaTechnologist.com, Sanofi-Aventis Defends Plavix Patent at Canada's Highest Court - Apr 16, 2008 Apotex claims that clopidogrel bisulfate, the active ingredient, was covered by a patent that expired in 2003. Sanofi maintains that the earlier patent Bloomberg Answering Questions On Improvising Musicians, Shyness And Lawyer ... - Apr 14, 2008 Question: Should you take Plavix (clopidogrel bisulfate) if you have an ulcer? Answer: No, and that's made clear by the manufacturer, Sanofi-Aventis: "If Evening Bulletin, Popularity of anti-VEGF therapies sparks debate over when and how ... - Apr 17, 2008 Dr. Puliafito: Now, do you think that if you are taking Plavix (clopidogrel bisulfate, Bristol-Myers Squibb/Sanofi Aventis) and you get macular degeneration OSN SuperSite (subscription), Pre-Thrombolysis Antiplatelet Therapy Enhances Ischemic Stroke ... - 11 Mar 2008 ...and clopidogrel bisulfate monotherapy (1.1%). In patients with prior antiplatelet therapy, 12 (13.5%) developed symptomatic intracerebral hemorrhage. MedPage Today, New 300mg Loading Dose Tablet for Plavix(R) Receives Positive ... - Mar 7, 2008 Evaluation Agency (EMEA) has issued a positive opinion recommending approval of the 300mg tablet of the antiplatelet Plavix(R) (clopidogrel bisulfate). Lifescience-online, New 300mg Loading Dose Tablet for Plavix(R) Receives Positive ... - Mar 5, 2008 Agency (EMEA) has issued a positive opinion recommendingapproval of the 300mg tablet of the antiplatelet Plavix(R)(clopidogrel bisulfate). Juraforum.de, New 300mg Loading Dose Tablet For Plavix Gets Positive Opinion ... - Mar 5, 2008 Medicines Evaluation Agency issued a positive opinion recommending sanction of the 300mg tablet of the antiplatelet Plavix, or clopidogrel bisulfate. RTT News, Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp ... - Feb 12, 2008 Apotex had launched a generic clopidogrel bisulfate in August 2006, following which the US District Court for the Southern District of New York awarded PR Newswire (press release), Sanofi-Aventis says generic Plavix launch by Dr. Reddy 'highly ... - Jan 17, 2008 BY: Dr. Reddy's received marketing approval from the US Food & Drug Administration for Clopidogrel Bisulfate, a generic version of Sanofi's blood-thinning MarketWatch Sanofi Aventis sees no Plavix copy despite FDA - Jan 18, 2008 The US Food and Drug Administration said on Wednesday it had approved pills containing clopidogrel bisulfate, the active ingredient in Plavix, Reuters Dr. Reddy's Gets FDA Approval to Sell Generic Plavix in US - Jan 16, 2008 The US Food and Drug Administration allowed Hyderabad- based Dr. Reddy's to sell tablets of clopidogrel bisulfate, or generic Plavix, the regulator said on Bloomberg Bristol-Myers Squibb Company Reports Financial Results for the ... - Jan 31, 2008 Estimated total US prescription demand for clopidogrel bisulfate (branded and generic) increased by 6% in the fourth quarter of 2007 compared to 2006. CNNMoney.com Sanofi-aventis Announces a Good Third Quarter Performance ... - Oct 31, 2007 Apotex launched a generic clopidogrel bisulfate in August 2006, following which the US District Court for the Southern District of New York awarded sanofi- CNNMoney.com Higher R&D Costs to Eat Sales Gains for Daiichi Sankyo - Nov 5, 2007 The study compared the effects of the drug to Bristol-Myers Squibb’s blockbuster Plavix (clopidogrel bisulfate). The main driver of Daiichi Sankyo’s R&D FDA news (subscription), Prasugrel Found to Reduce Death Risk But Increase Major Bleeding - Nov 12, 2007 ...nonfatal heart attacks and nonfatal strokes compared with those taking Bristol-Myers Squibb and sanofi-aventis’ Plavix (clopidogrel bisulfate). FDA news (subscription), FDA Approves New 300mg Loading Dose Tablet for PLAVIX® - Oct 23, 2007 ...today that the FDA has approved a supplemental new drug application(snda) for a 300mg tablet of the antiplatelet PLAVIX® (clopidogrel bisulfate). Pharmaceutical Processing, Bristol-Myers Squibb Company Reports Financial Results for the ... - Oct 25, 2007 Estimated total US prescription demand for clopidogrel bisulfate (branded and generic) increased by 7% in the third quarter of 2007 compared to 2006. CNNMoney.com Sanofi-Aventis Q3 Adj. Profit Up 9.1%; Lifts FY07 Adj. EPS Growth ... - Oct 31, 2007 The company noted that the product has been affected since August 8, 2006 by the launch of a generic clopidogrel bisulfate by Apotex. sanofi-aventis was RTT News, Search By Symbol - Oct 25, 2007 The company said that estimated total US prescription demand for clopidogrel bisulfate, branded and generic, increased 7% in the quarter from a year ago, RTT News, FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R ... - Sep 27, 2007 WHO SHOULD RECEIVE Plavix (clopidogrel bisulfate)? -- Recent Myocardial Infarction (MI), Recent Stroke, or Established Peripheral Arterial Disease (PAD) For CNNMoney.com Plavix 300 mg Tablets Approved - Oct 1, 2007 The FDA has approved Sanofi-Aventis’ SNDA for Plavix (clopidogrel bisulfate) 300 mg tablets for use in appropriate acute coronary syndrome (ACS) patients as Facts and Comparisons, Groups Ask Lawmakers to Support Generic Drug Access - Oct 4, 2007 ...year when it placed Thailand on the Special 301 Priority Watch List for issuing compulsory licenses for two HIV drugs and Plavix (clopidogrel bisulfate). FDA news (subscription), US FDA approves new 300 mg loading dose tablet for Plavix(R) - Sep 27, 2007 Food and Drug Administration has approved a supplemental new drug application for a 300 mg tablet of the antiplatelet PLAVIX(R)(clopidogrel bisulfate). CNNMoney.com To each his own when it comes to dogs - Sep 5, 2007 Purdue University in Indiana, is investigating the use of an anti-clotting drug commonly used in human medicine called Clavix (Clopidogrel Bisulfate). Montreal Gazette, [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |